000 01328 a2200385 4500
005 20250511205859.0
264 0 _c19920109
008 199201s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/0277-5379(91)90305-w
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKok, T C
245 0 0 _aIfosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c1991
300 _a1112-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aEsophageal Neoplasms
_xdrug therapy
650 0 4 _aEsophagogastric Junction
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xadverse effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPrognosis
650 0 4 _aTreatment Refusal
700 1 _avan der Gaast, A
700 1 _aSplinter, T A
700 1 _aTilanus, H W
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 27
_gno. 9
_gp. 1112-4
856 4 0 _uhttps://doi.org/10.1016/0277-5379(91)90305-w
_zAvailable from publisher's website
999 _c1841823
_d1841823